Trademark: 79301293
Word
AKZYSA
Status
Registered
Status Code
700
Status Date
Tuesday, July 6, 2021
Serial Number
79301293
Registration Number
6405997
Registration Date
Tuesday, July 6, 2021
Mark Type
4000
Filing Date
Monday, November 9, 2020
Published for Opposition
Tuesday, April 20, 2021

Trademark Owner History
Sandoz AG -
NOVARTIS AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Jan 19, 2024
Change Of Owner Received From Ib
Nov 15, 2021
Final Decision Transaction Processed By Ib
Oct 25, 2021
Final Disposition Notice Sent To Ib
Oct 25, 2021
Final Disposition Processed
Oct 6, 2021
Final Disposition Notice Created, To Be Sent To Ib
Jul 6, 2021
Registered-Principal Register
Apr 20, 2021
Official Gazette Publication Confirmation E-Mailed
Apr 20, 2021
Published For Opposition
Apr 19, 2021
Notification Processed By Ib
Mar 31, 2021
Notification Of Possible Opposition Sent To Ib
Mar 31, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 31, 2021
Notification Of Notice Of Publication E-Mailed
Mar 22, 2021
Refusal Processed By Ib
Mar 12, 2021
Approved For Pub - Principal Register
Mar 11, 2021
Teas/Email Correspondence Entered
Mar 11, 2021
Correspondence Received In Law Office
Mar 11, 2021
Teas Response To Office Action Received
Mar 4, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 4, 2021
Teas Change Of Correspondence Received
Mar 4, 2021
Teas Change Of Domestic Representatives Address
Mar 4, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 4, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 4, 2021
Teas Change Of Owner Address Received
Mar 2, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Mar 2, 2021
Refusal Processed By Mpu
Feb 24, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Feb 23, 2021
Non-Final Action Written
Feb 23, 2021
Assigned To Examiner
Jan 19, 2021
Application Filing Receipt Mailed
Jan 14, 2021
New Application Office Supplied Data Entered
Jan 13, 2021
Limitation From Original Application Entered
Dec 31, 2020
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24